A venture backed and Cleveland, OH based healthcare technology company, GenomOncology is enabling precision medicine by transforming data into actionable information.
We offer the GO Precision Medicine Portfolio - a suite of solutions that addresses the full range of needs for Healthcare Institutions. The portfolio supports technical assay validation and testing, clinical decision support, collaborative decision support for Molecular Tumor Board workflows and analytics for monitoring and discovery – to enable cancer precision medicine.